The compound starves tumors of an amino acid, cysteine, which was found to be critical to the survival of pancreatic cancer cells.The study, conducted in mice with pancreatic cancer, was published online today in the journal Science. Read more . . .
A new study from Columbia University Irving Medical Center and the Herbert Irving Comprehensive Cancer Center suggests a compound in development for a rare kidney stone disease may have potential against pancreatic cancer.